J. Lubiński

发表

CHEK2 is a multiorgan cancer susceptibility gene.

J. Lubiński, S. Narod, E. Grabowska, 2004, American journal of human genetics.

BRCA1-positive breast cancers in young women from Poland

W. Kozlowski, J. Ryś, K. Lamperska, 2006, Breast Cancer Research and Treatment.

A common variant of CDKN2A (p16) predisposes to breast cancer

S. Narod, C. Szczylik, A. Mackiewicz, 2005, Journal of Medical Genetics.

Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation

J. Kładny, A. Jakubowska, C. Cybulski, 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Vitamin D receptor variants and the malignant melanoma risk: a population-based study.

C. Cybulski, T. Byrski, T. Huzarski, 2009, Cancer epidemiology.

BRCA2 gene mutations in families with aggregations of breast and stomach cancers

R. Scott, A. Jakubowska, J. Lubiński, 2002, British Journal of Cancer.

Selenium as marker for cancer risk and prevention.

J. Kładny, S. Gupta, A. Jakubowska, 2012, Polski przeglad chirurgiczny.

Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation

J. Lubiński, S. Neuhausen, S. Narod, 2013, Clinical genetics.

Polymorphism of GSTM1 gene in patients with colorectal cancer and colonic polyps.

J. Kładny, J. Lubiński, D. Bielicki, 1999, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

NOD2 variants and the risk of malignant melanoma

C. Cybulski, T. Byrski, T. Huzarski, 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.

W. Foulkes, S. Neuhausen, M. Robson, 2014, Current oncology.

Frequency and nature of hMSH6 germline mutations in Polish patients with colorectal, endometrial and ovarian cancers

J. Kładny, K. Safranow, G. Kurzawski, 2006, Clinical genetics.

Ovarian cancer of endometrioid type as part of the MSH6 gene mutation phenotype

A. Jakubowska, J. Lubiński, Janina Suchy, 2002, Journal of Human Genetics.

Common variants of DNA repair genes and malignant melanoma.

J. Kładny, A. Jakubowska, C. Cybulski, 2008, European journal of cancer.

Value of pedigree/clinical data, immunohistochemistry and microsatellite instability analyses in reducing the cost of determining hMLH1 and hMSH2 gene mutations in patients with colorectal cancer.

J. Kładny, T. Dębniak, B. Górski, 2000, European journal of cancer.

Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool.

J. Kładny, T. Dębniak, G. Kurzawski, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sézary syndrome.

K. Mrózek, J. Lubiński, J. Limon, 1995, Cancer genetics and cytogenetics.

Novel germline mutations in the adenomatous polyposis coli gene in Polish families with familial adenomatous polyposis

M. Drews, D. Lipiński, A. Pławski, 2004, Journal of Medical Genetics.

breast cancer A common variant of CDKN2A (p16) predisposes to

S. Narod, C. Szczylik, A. Mackiewicz, 2005 .

Germline MSH2 and MLH1 mutational spectrum in HNPCC families from Poland and the Baltic States

J. Kładny, A. Jakubowska, K. Safranow, 2002, Journal of medical genetics.

Founder mutations of BRCA1 and BRCA2 in North American families of Polish origin that are affected with breast cancer.

S. Narod, H. Lynch, E. Jack, 2001, American journal of human genetics.

Xeroderma pigmentosum genes and melanoma risk

R. Scott, C. Cybulski, T. Dębniak, 2013, International journal of cancer.

Translocation (X;1)(p11.2;q21) in a papillary renal cell carcinoma in a 14-year-old girl.

J. Limon, J. Gronwald, J. Lubiński, 1998, Cancer genetics and cytogenetics.

Wiskott‐Aldrich syndrome: case presentation with molecular genetic analysis for clonality

J. Lubiński, E. Kamieńska, A. Krygier-Stojałowska, 1992, Acta paediatrica.

R. Scott, A. Jakubowska, J. Lubiński, 2011, PloS one.

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers

P. Møller, W. Foulkes, J. Iqbal, 2012, British Journal of Cancer.

New EPCAM founder deletion in Polish population

A. Pławski, T. Byrski, T. Huzarski, 2017, Clinical genetics.

Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.

T. Huzarski, P. Serrano-Fernández, B. Masojć, 2009, Anticancer research.

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband

J. Lubiński, S. Narod, P. Sun, 2009, British Journal of Cancer.

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study

Charis Eng, Fergus Couch, Kevin Sweet, 2013, British Journal of Cancer.

Survival in patients with rare subtypes of renal cell carcinoma

T. Huzarski, M. Grabowski, J. Lubiński, 2002, BJU international.

Survival of Laryngeal Cancer Patients Depending on Zinc Serum Level and Oxidative Stress Genotypes

R. Scott, K. Białkowska, J. Lubiński, 2021, Biomolecules.

Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study)

J. Kładny, A. Jakubowska, K. Safranow, 2005, Clinical genetics.

[Morphology of the glottis and perceptiv-acoustic characteristic of the voice and speech after extended fronto-lateral epiglotttoplasty].

J. Lubiński, E. Jaworowska, Katarzyna Amernik, 2009, Otolaryngologia polska = The Polish otolaryngology.

Cumulative effects of genetic markers and the detection of advanced colorectal neoplasias by population screening

J. Lubiński, E. Małecka-Panas, T. Dębniak, 2015, Clinical genetics.

Age at diagnosis to discriminate those patients for whom constitutional DNA sequencing is appropriate in sporadic unilateral retinoblastoma.

A. Jakubowska, G. Kurzawski, J. Lubiński, 1998, European Journal of Cancer.

Correction: A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

A. Jakubowska, J. Lubiński, K. Durda, 2013, PLoS ONE.

A Low Selenium Level Is Associated with Lung and Laryngeal Cancers

A. Jakubowska, K. Durda, S. Narod, 2013, PloS one.

Serum selenium levels and the risk of progression of laryngeal cancer

A. Jakubowska, S. Narod, J. Kotsopoulos, 2018, PloS one.

Correction: Serum selenium levels and the risk of progression of laryngeal cancer

A. Jakubowska, S. Narod, J. Kotsopoulos, 2018, PloS one.

Selenium as a marker of cancer risk and of selection for control examinations in surveillance

J. Kładny, R. Scott, A. Jakubowska, 2015, Contemporary oncology.

The -149C>T SNP within the DeltaDNMT3B gene, is not associated with early disease onset in hereditary non-polyposis colorectal cancer.

J. Lubiński, C. Meldrum, Janina Suchy, 2008, Cancer letters.

Lynch syndrome mutations shared by the Baltic States and Poland

J. Kładny, A. Metspalu, T. Byrski, 2014, Clinical genetics.

Frequency of Cytogenetic Aberrations and their Influence on Results of Treatment in Childhood Acute Lymphoblastic Leukemia (ALL)

A. Kołtan, J. Lubiński, M. Wysocki, 2003 .

Familial association of laryngeal, lung, stomach and early-onset breast cancer

R. Scott, S. Narod, P. Serrano-Fernández, 2008, Breast Cancer Research and Treatment.

Population screening for cancer family syndromes in West-Pomeranian Region of Poland with 1.7 min inhabitants

C. Cybulski, T. Byrski, T. Huzarski, 2004 .

The risk of breast cancer in BRCA1 and BRCA2 mutation carriers without a first‐degree relative with breast cancer

H T Lynch, B. Karlan, W. Foulkes, 2018, Clinical genetics.

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

A. Jakubowska, J. Lubiński, S. Narod, 2000, American journal of human genetics.

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

D. Easton, J. Hopper, D. Easton, 2005, Journal of Medical Genetics.

NBS1 Is a Prostate Cancer Susceptibility Gene

A. Jakubowska, J. Lubiński, S. Narod, 2004, Cancer Research.

Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene

A. Jakubowska, J. Lubiński, L. Sagan, 2002, Journal of medical genetics.

Breast cancer predisposing alleles in Poland

A. Jakubowska, J. Lubiński, S. Narod, 2005, Breast Cancer Research and Treatment.

A survey of preventive measures among BRCA1 mutation carriers from Poland

J. Lubiński, S. Narod, P. Sun, 2007, Clinical genetics.

Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene

S. Richard, C. Cybulski, E. Maher, 1999, Human Genetics.

Combined iPLEX and TaqMan assays to screen for 45 common mutations in Lynch syndrome and FAP patients

J. Kładny, J. Lubiński, R. Słomski, 2011, The Journal of molecular diagnostics : JMD.

CHEK2 variants predispose to benign, borderline and low-grade invasive ovarian tumors.

J. Lubiński, A. Sokolenko, E. Imyanitov, 2006, Gynecologic oncology.

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)

T. Dębniak, G. Kurzawski, J. Suchy, 2012, Hereditary Cancer in Clinical Practice.

A protein truncating BRCA1 allele with a low penetrance of breast cancer

J. Lubiński, S. Narod, J. Gronwald, 2004, Journal of Medical Genetics.

Cancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status

J. Lubiński, A. Monteiro, S. Narod, 2005, Journal of Medical Genetics.

Age at diagnosis of cancer as predictor of mutation occurrence in families suspected of HNPCC.

J. Kładny, T. Dębniak, G. Kurzawski, 2001, Journal of applied genetics.

Fast diagnostic test for the identification of an increased genetic predisposition to colon cancer (exemplified on a DNA test for recurrent mutations of the gene MMR)

T. Dębniak, G. Kurzawski, J. Suchy, 2012, Hereditary Cancer in Clinical Practice.

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

S. Narod, C. Cybulski, T. Byrski, 2011, Hereditary Cancer in Clinical Practice.

Cisplatin chemotherapy in the treatment of BRCA1-positive metastatic breast cancer (MBC).

J. Lubiński, S. Narod, C. Cybulski, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical and epidemiological features of familial laryngeal cancer in Poland.

J. Lubiński, P. Serrano-Fernández, J. Lubiński, 2007, Cancer detection and prevention.